Ovarian cancer
RecruitingStudy of THEO-260 for Patients with High-Grade Serous or Endometrioid Ovarian Cancer
- Disease:Ovarian cancer
- Substances:–
Spain- Participants:18–64 years · 65+ years
- Sponsor:Theolytics Limited
Rare diseases
Investigational molecules
Locations
4610 Kingsgate, Cascade Way, Arc Oxford, OX4 2SU, United Kingdom
Theolytics Limited is engaged in clinical research for high grade serous ovarian cancer and endometrioid ovarian cancer, with a focus on advanced gynaecological oncology.
The sponsor’s research activity is centred on treatment development for patients with difficult-to-treat ovarian malignancies.
Theolytics Limited runs clinical trials in conditions such as Ovarian cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.